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Type 2 diabetes mellitus (T2DM) has become prevalent pandemic disease in view of the modern life
style. Both diabetic population and health expenses grow rapidly according to American Diabetes
Association. Detecting the potential onset of T2DM is an essential focal point in the research of
diabetes mellitus. The intravenous glucose tolerance test (IVGTT) is an effective protocol to
determine the insulin sensitivity, glucose effectiveness, and pancreatic b-cell functionality, through the
analysis and parameter estimation of a proper differential equation model. Delay differential equations
have been used to study the complex physiological phenomena including the glucose and insulin
regulations. In this paper, we propose a novel approach to model the time delay in IVGTT modeling.
This novel approach uses two parameters to simulate not only both discrete time delay and distributed
time delay in the past interval, but also the time delay distributed in a past sub-interval. Normally,
larger time delay, either a discrete or a distributed delay, will destabilize the system. However, we find
that time delay over a sub-interval might not. We present analytically some basic model properties,
which are desirable biologically and mathematically. We show that this relatively simple model pro-
vides good fit to fluctuating patient data sets and reveals some intriguing dynamics. Moreover, our
numerical simulation results indicate that our model may remove the defect in well known Minimal
Model, which often overestimates the glucose effectiveness index. Published by AIP Publishing.
https://doi.org/10.1063/1.5008384
Delay differential equations (DDEs) have been frequently
used to study complex dynamics observed in nature.
More recently, they are used to understand intriguing
physiological phenomena such as those expressed by glu-
cose and insulin interaction. We propose a simple set of
delay differential equations to model an intravenous glu-
cose tolerance test. This model uses two parameters to
simulate not only both discrete time delay and distributed
time delay in the past interval, but also the time delay dis-
tributed in a past sub-interval. We show that this rela-
tively simple model provides good fit to fluctuating
patient data sets and reveals some intriguing dynamics.
Most importantly, our model may remove the defect in
the well known Minimal Model (MM) which often over-
estimates the glucose effectiveness (GE) index.
I. INTRODUCTION
Diabetes Mellitus continues to be a leading public health
concern, contributing to an overwhelming number of debili-
tating health ailments, pre-mature death, and billions of dol-
lars ($245 billion in the US in 2012) in medical care costs.
Approximately 29.1 million or 12.3% of American adults
age 20 or older have diabetes.1 Worldwide, there are an esti-
mated 422 million individuals with diabetes mellitus.
Additionally, 79 million individuals have prediabetes, a con-
dition that progresses to Type 2 diabetes mellitus (T2DM) at
higher than normal rate. The pathogenesis of type 2 diabetes
is complex and is mainly related to a progressive increase in
insulin resistance (IR) and decline in insulin secretion, while
other factors including changes in incretin hormones and
renal handling of glucose excretion also play a role.2 Defects
in insulin resistance and insulin secretion are seen early in
the course of disease, in fact in the prediabetes phase.3
Understanding the mechanisms of insulin resistance and
defective insulin secretion could provide an opportunity to
develop strategies to prevent and treat diabetes.
Insulin is secreted from pancreas in a pulsatile manner
under basal conditions with a frequency of 5 to 15min. Such
regular oscillatory secretion is impaired in type 2 diabetes
mellitus (T2DM).4 Defects in pulsatile insulin secretion have
been demonstrated in early T2DM and in the relatives of
subjects with T2DM.5 Insulin response to a glucose load
sometimes occurs in two phases—a rapid first phase with
dramatic increase in insulin levels, followed by a smaller but
prolonged second phase that can form a second peak in insu-
lin levels. Loss of first phase insulin secretion occurs early in
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the course of prediabetes and T2DM.3 Legacy work by
O’Rahilly et al.6 showed that a significant peak at 13 to
14min exists in the insulin dynamics of the non-diabetic
people, but it is lacking in type 2 diabetic individuals and the
relatives of T2DM. Thus, it is concluded that the lack of
expected oscillatory insulin secretion in the first degree rela-
tives of type 2 diabetics is believed to be an early diagnostics
in the progression of type 2 diabetes.6 This peak at 13 to
14min mark could be caused by the time lag from the insulin
secretion to when the insulin is transported to interstitial
space where insulin helps cells to uptake glucose.
Furthermore, reduced glucose effectiveness is also an early
change in T2DM and has been noted to be reduced in nondi-
abetic relatives of individuals with T2DM.7
A key methodological aspect of evaluating insulin resis-
tance and insulin secretion is the development of methods to
accurately measure these parameters reliably in a wide vari-
ety of physiological situations. The Frequently Sampled
Intravenous glucose Tolerance test (fsIVGTT) has been
widely used as tool to measure insulin sensitivity (IS), insu-
lin secretion, and glucose effectiveness (GE).8 In fsIVGTT,
after an overnight fasting, the subject is given a bolus of glu-
cose (300 g/kg) through intravenous, followed by sampling
plasma glucose and serum insulin at time marks 20, 40, 60, 80,
100, 120, 140, 180, 210, 240, 300, 350, 400, 450, 500, 600, 700, 800,
900, 1000, 1200, 1400, 1600, and 1800. The sampled data are
often analyzed by using a mathematical model, and rich
physiological information is thus revealed, including insulin
sensitivity and glucose effectiveness. The values of the insu-
lin sensitivity index Si (in the order of 10
5 or 104) and the
glucose effectiveness index Sg (in the order of 10
2 and
103) are calculated by the expressions of the parameters of
the mathematical model. The most widely used model is the
Minimal Model (MM) by Bergman et al.9,10 The insulin sen-
sitivity index (Si) is closely related to the IS determined by
the hyperinsulinemic euglycemic glucose clamp test.11 A
commercial software, Penn Millennium MINMOD,12 was
developed based on MM.13,14 However, it has been noticed
that MM overestimates glucose effectiveness.15,16
The MM is a three dimensional ordinary differential
equation (ODE) system including glucose concentration in
plasma and insulin concentration in interstitial space as state
variables, while insulin concentration in plasma as an input
to the interstitial space. The split of the two compartments
can be thought of implicitly simulating the time delay of
insulin secretion stimulated by the elevated glucose level.
Since then, many IVGTT and related models have been pro-
posed in the forms of delay differential equation (DDE) sys-
tems in a single compartment incorporating the time delay
explicitly.17–22 De Gaetano and Arino18 in 2000 introduced
the following aggregated DDE model with a distributed time
delay over the past interval
G0ðtÞ ¼ b7  b1G  b4GI
I0ðtÞ ¼ b6
b5
ðt
tb5
GðsÞds  b2I;
8<
: (1.1)
with the initial conditions Gð0Þ ¼ Gb þ b0; Ið0Þ ¼ Ib þ b3b0
andGðtÞ ¼ Gb; t 2 ½b5; 0Þ, the constant parameters
b7; b1; b4; b6; b5 and b2 stand for hepatic glucose production,
glucose effectiveness, insulin sensitivity, maximal insulin
secretion stimulated by glucose, time delay, and insulin deg-
radation rate, respectively. In 2001, Li et al.23 generalized
the Model (1.1) to the following form:
G0ðtÞ ¼ b7  f ðGðtÞÞ  gðGðtÞ; IðtÞÞ;
I0ðtÞ ¼ qðLðGtÞÞ  pðIðtÞÞ;
(
(1.2)
where f ðGÞ; gðG; IÞ and pðIÞ stand for insulin independent
glucose uptake, insulin dependent glucose utilization and
insulin degradation, respectively. qðLðGtÞÞ is the insulin
secretion stimulated by glucose with discrete time delay
LðGtÞ ¼ Gðt  b5Þ or distributed time delay LðGtÞ ¼ 1b5Ð 0
b5 Gðt þ hÞdh. The readers are referred to Ref. 23 for the
shapes of the function f ; g; p and q and relevant details. It is
demonstrated in Ref. 23 that the Hopf bifurcation exists for
both types of time delays, distributed in the whole past
interval ½b5; 0 and discretely at a single point back b5
minutes. Later, De Gaetano and his colleagues also gener-
alized the Model (1.1) to a family of DDE models in
200722 in which general delays in both insulin action on
tissue glucose uptake and in the glucose action on pancre-
atic insulin secretion are considered. On the other hand, De
Gaetano and his colleagues claimed that a simplified single
discrete time delay model24 is good enough to test the insu-
lin sensitivity, and they discussed further the advantage of
the simplified model.25 In 2012, Li et al.26 discussed the
range of time delay and provided easy-to-check conditions
for the globally asymptotic stability of the equilibrium
point for the IVGTT model with a discrete time delay
through Liapunov function approach.
Time delay of insulin secretion stimulated by increasing
glucose may well be distributed in a past time sub-interval
½t  s2; t  s1, instead of concentrated at a single time of the
past (a discrete delay), or evenly distributed in a whole past
interval ½t  s; t. In this paper, we introduce a novel and
generic approach to modeling such delayed effect as follows:
G0ðtÞ ¼ b  SgG  SiGI
I0ðtÞ ¼ rf ðLðGtÞÞ  diI;
(
(1.3)
with initial conditions GðtÞ ¼ /ðtÞ; t 2 ½s ; 0, where
b; Sg; Si; r, and di > 0 are parameters for the hepatic glucose
production, glucose effectiveness, insulin sensitivity, maxi-
mal rate of insulin secretion stimulated by glucose and the
insulin degradation rate, respectively. Two parameters s > 0
and 0 <   s together represent the time delay of insulin
secretion as below
LðGtÞ ¼ 1
2
ðsþ
s
Gðt þ hÞdh (1.4)
and
f ðxÞ ¼ x
n
an þ xn for x  0; (1.5)
is a sigmoidal function with n  2 and the half saturation
value a > 0. f(x) depicts the phenomenon that when insulin
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secretion is low when glucose level is low, but increases
quickly when glucose level is elevated to some threshold
level.27 The time delay in (1.4) is distributed in the interval
½s ;sþ . In other words, the secretion rate of insulin
at current time t> 0 is related to the glucose level in the past
sub-interval ½t  s ; t  sþ . For the sake of conve-
nience, we call average time delay s the center of delay and 
the radius of the delay interval.
It is easy to see that LðGtÞ ¼ 12s
Ð 0
2s Gðt þ hÞdh when
 ¼ s. It takes the same form as b5 ¼ 2s in the model (2.3) in
Ref. 23 and Eq. (5) in Ref. 18.
When  ! 0; LðGtÞ ¼ Gðt  sÞ, it reduces to the dis-
crete delay LðGtÞ ¼ Gðt  sÞ in the model (2.2) in Ref. 23.
Then (1.3) can be rewritten as
G0ðtÞ ¼ b  SgG  SiGI
I0ðtÞ ¼ rf ðGðt  sÞÞ  diI;
(
(1.6)
where GðtÞ ¼ /ðtÞ; t 2 ½s; 0. According to Lebesgue’s
Dominated Convergence Theorem, we can show that the solu-
tion ðGðtÞ; IðtÞÞ of (1.3) tends to the solution ðGðtÞ; IðtÞÞ of
(1.6) as  ! 0.
The initial conditions of Model (1.3) are
uðtÞ ¼ Gb; for t 2 s ;d½ ;
G0 þ d1ðG0 GbÞt; for t 2 d;0½ ;
(
(1.7)
while Ið0Þ ¼ Ib. Here, Gb and Ib are the basal levels of the
blood glucose and insulin concentration levels, t¼ 0 is the
ending time of the bolus glucose infusion, and 0 < d < s is
the total time needed for the bolus glucose infusion and the
time for glucose and insulin to increase from basal levels
to the first peak levels. Usually, it takes 2min for glucose
infusion.
We organize this paper as follows. In Sec. II, the positiv-
ity and uniform boundedness of the solutions of the model is
established. In fact, we also show solutions are eventually
uniformly bounded away from zero. In Sec. III, we provide
some sufficient conditions that ensure the unique positive
equilibrium is asymptotically or globally asymptotically
stable. In Sec. IV, we investigate the existence of the Hopf
bifurcation when s or  varies and when both vary. In Sec. V,
we fit our model with clinical data sets and demonstrate
some of the interesting phenomena revealed by the new
model. A brief discussion on the implications of our results
are presented in the last section.
II. PRELIMINARIES
In this section, we present some basic results, such as
the positive invariance of system (1.3), the existence of equi-
librium, the boundedness of solutions and the persistence of
the system.
Proposition 2.1. The solutions ðGðtÞ; IðtÞÞ of system
(1.3) are positive and bounded.
Proof. Let ðGðtÞ; IðtÞÞ be a solution of System (1.3). If
there exists a t0 > 0 such that Gðt0Þ ¼ 0 but G(t)> 0 for
t 2 ½0; t0, then G0ðt0Þ  0. But the first equation of (1.3)
implies that G0ðt0Þ ¼ b > 0. This shows that G(t)> 0 for all t
in the interval of its existence. Similarly, if there exists a
t0 > 0 such that Iðt0Þ ¼ 0 but I(t)> 0 for t 2 ½0;t0, then
from the second equation of (1.3), I0ðt0Þ ¼ rf ðLðGðt0ÞÞÞ
d2Iðt0Þ ¼ rf ðLðGðt0ÞÞ. Since Gt0ðhÞ ¼ Gðt0 þ hÞ > 0 for
h 2 ½s ; 0, then f ðLðGðt0ÞÞÞ > 0 by the definition of the
function f. Thus, I0ðt0Þ > 0, which shows that I(t)> 0 for all
t in the interval of its existence. As for the boundedness of
G(t), by the first equation of (1.3)
G0ðtÞ  b  SgG:
Thus, G(t) is bounded by GM :¼ maxf/ðtÞ; b=Sgg. Then,
by the second equation of (1.3) we can obtain
I0ðtÞ  rf ðGMÞ  diI:
Thus, I(t) is bounded by IM :¼ maxfIð0Þ; rf ðGMÞ=dig.
The boundedness statement implies that the solution exists
for all t> 0. 
Proposition 2.2. System (1.3) is persistent, that is, solu-
tions of (1.3) are ultimately bounded from above and from
below by a positive lower bound.
Proof. From the proof of Proposition 2.1, we know that
GðtÞ < GM for all t > 0 (2.1)
and
IðtÞ < IM for all t > 0: (2.2)
Thus, we only need to find the solutions’ positive bound
from below.
From the first equation of (1.3) and (2.2), we have
G0ðtÞ  b  SgG  SiGIM:
Therefore,
GðtÞ  Gð0Þ  b
Sg þ SiIM
 
eðSgþSiIMÞt
þ b
Sg þ SiIM for all t > 0;
which implies that
GðtÞ  b
Sg þ SiIM  g1 :¼ Gm > 0 for some g > 0:
Then, from the second equation of (1.3), we can derive that
I0ðtÞ  rf ðGmÞ  diI:
Hence
IðtÞ  Ið0Þ  rf ðGmÞ
di
 
edit þ rf ðGmÞ
di
for t > 0:
Then, for some g > 0
IðtÞ > rf ðGmÞ
di
 g :¼ Im:
From above, we conclude that the solutions of (1.3) are
eventually bounded from above and away from zero. 
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III. STABILITYOF THE EQUILIBRIUM
In this section, we will discuss the local and global
stability of the positive equilibrium ðG; IÞ of system (1.3),
respectively.
Consider the algebraic equations defining any equilib-
rium point ðG; IÞ
b  SgG  SiGI ¼ 0;
rf ðGÞ  diI ¼ 0:

(3.1)
Clearly
I ¼ rf ðG
Þ
di
and
b  SgG  SiG rf ðG
Þ
di
¼ 0:
Let
FðGÞ ¼ b  SgG  SiG rf ðGÞ
di
for all G  0:
Then, Fð0Þ ¼ b > 0 and
Fðþ1Þ¼ lim
G!þ1
FðGÞ¼ lim
G!þ1
bSgGSiGrf ðGÞ
di
 
¼1:
Furthermore
dFðGÞ
dG
¼ Sg  Sir
di
f ðGÞ  Sir
di
Gf 0ðGÞ:
Since f(G)> 0 for G> 0, f 0ðGÞ > 0 for G> 0. Thus,
FðÞ is a decreasing function for the arguments and it may
hence have a unique positive root ðG; IÞ. That is, the
Model (1.3) has a unique equilibrium point ðG; IÞ.
In IVGTT, the blood glucose and insulin concentration
levels return to their basal level after about three hours. So,
we assume that G ¼ Gb and I ¼ Ib. Then, we have
b  SgGb  SiGbIb ¼ 0;
rf ðGbÞ  diIb ¼ 0:

Thus
di ¼ rf ðGbÞ
Ib
and b ¼ SgGb  SiGbIb;
and therefore, the number of parameters of the Model (1.3)
is reduced to 7.
Applying the same method of Theorem 3.1 in Ref. 23,
the following straight forward result is proved, which is con-
sistent with the conclusion ðA4Þ for the discrete delay model
in Ref. 26 on the global stability of the positive steady state.
Theorem 3.1. If n  1, then the unique equilibrium
point ðG; IÞ of (1.3) is globally asymptotically stable.
The above result on stability does not depend on the
value of the delay. In clinical test, the insulin release is
abrupt stimulated by the bolus glucose infusion into intrave-
nous, which implies that n> 1 to model the abrupt insulin
release. We now turn to consider the case for n> 1.
Consider the model (1.3). Let G1ðtÞ ¼ GðtÞ  G;
I1ðtÞ ¼ IðtÞ  I, then model (1.3) is transformed to
G01ðtÞ ¼ b  SgðG1ðtÞ þ GÞ  SiðG1ðtÞ þ GÞðI1ðtÞ þ IÞ;
I01ðtÞ ¼ rf ðLððG1ÞtÞ þ GÞ  diðI1ðtÞ þ IÞ:
(
(3.2)
The unique equilibrium point ðG; IÞ is mapped to (0, 0) for
(3.2). The linearized system of (3.2) about its equilibrium
point is given by
G02ðtÞ ¼ ðSg  SiIÞG2ðtÞ  SiGI2ðtÞ
I02ðtÞ ¼ diI2ðtÞ þ rf 0ðGÞLððG2ÞtÞ;
(
(3.3)
and the corresponding characteristic equation of (3.3) is
kþ Sg þ SiI SiG
 rf
0ðGÞ
2
ðsþ
s
ekhdh kþ di

 ¼ 0;
that is,
k2 þ ðSg þ SiI þ diÞkþ diðSiI þ SgÞ
þ SiG
rf 0ðGÞ
2
ðsþ
s
ekhdh ¼ 0: (3.4)
Denote
a ¼ Sg þ SiI þ di; c ¼ diðSiI þ SgÞ and h ¼ SiGrf 0ðGÞ:
(3.5)
Clearly a2  2c > 0, which is applied in Sec. IVA, and we
can rewrite (3.4) as
k2 þ akþ c þ h
2
ðsþ
s
ekhdh ¼ 0: (3.6)
When there is no delay, that is s¼ 0 and ¼ 0, the character-
istic equation becomes
k2 þ akþ c ¼ 0;
and the real parts of the eigenvalues are negative, which implies
that the trivial solution is globally asymptotically stable.
If the trivial solution of (3.3) is unstable for some s > 0
and  > 0, there must exist x > 0 such that k ¼ ix is a solu-
tion of (3.6), i.e.,
ðixÞ2 þ axiþ cþ h
2
ðsþ
s
ðcos ðxhÞ þ i sin ðxhÞÞdh ¼ 0;
(3.7)
that is,
x2þaxiþcþ h
2
ðsþ
s
cosðxhÞdhþi h
2
ðsþ
s
sin xhð Þdh¼0:
(3.8)
Thus, we have
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x2 þ c þ h
2
ðsþ
s
cosxhdh ¼ 0 (3.9)
and
axþ h
2
ðsþ
s
sinxhdh ¼ 0; (3.10)
which leads to
a ¼ hs sinx
x
 
sinxs
xs
 
 hs: (3.11)
Thus, we have proved the following theorem.
Theorem 3.2. If the delay center s < ah, then the trivial
solution of the linear system of the model (3.3) is globally
asymptotically stable.
Consequently, we have
Theorem 3.3. If the delay center
s < sb :¼ a
h
¼ ðSg þ SiIb þ diÞ=ðrSiGbf 0ðGÞÞ; (3.12)
then the positive equilibrium ðG; IÞ of (1.3) is locally
asymptotically stable.
Remark 3.4. From Theorem 3.1 and Theorem 3.3, we
find that when the parameters in the Model (1.3) are fixed,
the shape of the function f ðxÞ ¼ xnanþxn will affect the stability
of the Model (1.3). If n  1, f is in the shape of the
Michaelis-Menten kinetics. From Theorem 3.1, the model is
globally asymptotically stable independent of the time delay.
If n> 1, f(x) is in the sigmoidal shape. Notice that the inflec-
tion point of f is at Gr ¼ ðn1nþ1Þ
1
na < a as n> 1. The slope of f
attains its maximal value at Gr. Theorem 3.3 provides a
bound sb for the delay center s which depends on the slope
of f at the plasma glucose basal level. So if Gb < a, then
smaller a causes the bound sb smaller. When Gb is near to a,
larger n will cause larger f 0ðGbÞ and therefore smaller sb.
Thus, the two parameters n and a together along with large s
could destabilize the system (1.3). On the other hand, in the
clinical setup of IVGTT, both glucose and insulin levels will
return to their basal levels in about 3 h. This suggests that
Model (1.3) may not be destabilized with reasonable parame-
ter values. In Sec. IV, we will study when the system
becomes unstable.
IV. BIFURCATION ANALYSIS
In this section, we seek Hopf bifurcations with respect
to the parameters s and , respectively. We will show that for
s varying from small to large, the system (1.3) could become
unstable, and however, for  varying from small to large, the
system (1.3) could change from unstable to stable.
A. Hopf bifurcation with parameter s
We first show that a local Hopf bifurcation takes place
when the delay center s varies.
Notice that (3.6) can be rewritten as
FðkÞ ¼ k2 þ akþ c þ h
2k
eðsþÞk  eðsÞkð Þ ¼ 0: (4.1)
If as s increases, the trivial solution becomes unstable, then
there must be a s > 0 such that when s ¼ s, FðixÞ ¼ 0 for
some x > 0. And thus
ðixÞ2 þ aixþ c þ h
2ix
eðsþÞix  eðsÞixð Þ ¼ 0:
Equivalently,
x2 þ axi þ c  h
2x
ð2 sin ðxsÞ sin ðxÞÞi½
þ 2 cos ðxsÞ sin ðxÞ ¼ 0:
Hence,
cos ðxsÞ sin ðxÞ ¼ ðx
2  cÞx
h
;
sin ðxsÞ sin ðxÞ ¼ ax
2
h
8>><
>>:
(4.2)
and
x4 þ ða2  2cÞx2 þ c2 ¼ h
2
2x2
sin2 xð Þ;
s ¼ 1
x
cot1
x2  c
ax
:
8>><
>>:
(4.3)
Let
gðxÞ ¼ x4 þ ða2  2cÞx2 þ c2  h
2
2x2
sin2x: (4.4)
From (4.4), it is easy to find that
gð0þÞ ¼ c2  h2;
and
g
p

 
¼ p

 4
þ ða2  2cÞ p

 2
þ c2 > 0:
If c< h, then gð0þÞ < 0. Therefore, there exists at least one
root x^ 2 0; p
 
such that gðx^Þ ¼ 0.
Notice that a2  2c > 0 and sin x  x cos x > 0 for
0 < x < p. Thus
g0ðxÞ ¼ 4x3 þ 2ða2  2cÞx 2h
2
x2
cos ðxÞ sin ðxÞ
þ 2h
2
2x3
sin2 xð Þ
¼ 4x3 þ 2ða2  2cÞxþ 2h
2 sin x
x2
 sin x x cos x
x
 
> 0; (4.5)
for 0 < x < p. So we obtain the following lemma.
Lemma 4.1. If c< h, then the function gðxÞ in (4.4) has
a unique zero x^ 2 0; p
 
.
Lemma 4.1 implies that there exists a x^ > 0 such that
Fðix^Þ ¼ 0, which leads to
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Theorem 4.2. If c < h, then the system (1.3) undergoes
a Hopf bifurcation at
s^ :¼ 1
x^
cot1
x^2  c
ax^
 
; for 0 < x^ <
p

; (4.6)
when s > 0 increases.
The proof is given in Appendix A.
Remark 4.3. From Theorem 4.2, it is easy to find that
model (1.3) undergoes a Hopf bifurcation related not only to
the value of s, but also to the value of . We shall demon-
strate numerical investigation in Sec. V.
Next, we shall compare the delay lengths of the Hopf
bifurcation in the three different cases: discrete delay, dis-
tributed delay in the past whole interval, and the distributed
delay in the past sub-interval. In fact, the three type delay
models can be considered in the following three cases: (A)
 ! 0, (B)  ¼ s, and (C) 0 <  < s.
In case (C), let s^ and x^ satisfy (4.6). Now, we compare
the bifurcation value s^ with the bifurcation values in other
two cases.
Case (A). For  ! 0þ, the characteristic equation of
(3.3) becomes
k2 þ akþ c þ hesk ¼ 0: (4.7)
If ix1 is the root of (4.7), similar to the above approach, we
can obtain the following equation corresponding to the first
equation of (4.3):
x41 þ ða2  2cÞx21 þ c2 ¼ h2: (4.8)
Then, we can find that if c< h, Eq. (4.8) has a positive root
x1 ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ða2  2cÞ þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ða2  2cÞ2  4ðc2  h2Þ
q
2
vuut
:
In this case, s ¼ s1 ¼ 1x1 cot1
x2
1
c
ax1
	 

. Using the same
method in the proof of Theorem 4.2, we can also obtain
the result: For  ! 0, if c< h holds, then (1.3) undergoes a
Hopf bifurcation when s ¼ s1 ¼ 1x1 cot1
x2
1
c
ax1
	 

, and x1 ¼ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ða22cÞþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ða22cÞ24ðc2h2Þ
p
2
q
: Comparing the first equation of
(4.3) and (4.8), we can easily get x1 > x^. That is, for the
system (1.3), the bifurcation value in the case of the discrete
time delay is smaller than that in the case of the distributed
time delay. In other words, when the delay parameter s
increases, the system with discrete time delay is sooner to be
destabilized.
Case (B). For  ¼ s, the first equation of (4.3) can be
rewritten as
x42 þ ða2  2cÞx22 þ c2 ¼
h2
s2x22
sin2sx2: (4.9)
If a positive root x2 of (4.9) exists under some conditions,
then model (1.3) may undergo a bifurcation at
s2 ¼ 1x2 cot1
x2
2
c
ax2
. In the case (C),  < s, so we can compare
the value of the right hand side of the first equation (4.3)
with the right hand side of (4.9). Since
sin ðxÞ
x >
sin ðsxÞ
sx for
0 <  < s < p=x, we know that the root of (4.9) x2 < x^.
This possibly implies that the time delay distributed in a past
sub-interval is more likely to destabilize a system than the
time delay distributed in the whole past interval.
B. Hopf bifurcation with parameter 
In Sec. IVA, we have proved that the system can
undergo a Hopf bifurcation when s > 0 increases. In this
subsection, we investigate the Hopf bifurcation of the system
(1.3) when  > 0 varies.
From Sec. IVA, we know that if c< h, then the strictly
increasing function gðxÞ in (4.4) has a unique zero x^ with
0 < x^ < p. If further
g
p
2
 
¼ p
2
 4
þ ða2  2cÞ p
2
 2
þ c2  4h
2
p2
< 0;
which is equivalent to
 > p 2ðða2  2cÞ þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
a4  4a2cþ 16h2=p2
p
Þ
	 
1
2
; (4.10)
then the zero x^ 2 p
2 ;
p

 
. For this interval p
2 ;
p

 
, the charac-
teristic equation (3.6) must have a unique pair of pure imagi-
nary eigenvalues, which is dependent of s and .
From (4.3), we obtain that
ds
dx
¼  1
x2
cot1
x2  c
ax
 
 ax
2 þ ac
x 1þ x
2  c
ax
 2
ðaxÞ2
< 0;
(4.11)
and
dx
d
¼
2h2 sinðxÞ
2x
sinðxÞ
x
 cos xð Þ
 
4x3þ2xða2cÞþ2h2 sinðxÞ
x2
sinðxÞ
x
 cos xð Þ
 
< 0 for 0<x<
p

:
(4.12)
Therefore,
d
ds
> 0 for 0 < x <
p

: (4.13)
So, the relation between s and  determined by (4.3) is
monotonic. Notice also x! 0þ as s!1 and x!1 as
s! 0þ. Now, let s  s^ be fixed. Then, there exists a unique
 corresponding to s that satisfies (4.3). We will show that
Hopf bifurcation occurs at  when  >  decreases in the
following theorem whose proof is given in Appendix B.
Theorem 4.4. Given fixed s > s^, let  be determined
by (4.3). Assume that (4.10) holds. Then, when  > 
decreases, the system (1.3) undergoes a Hopf bifurcation at
 > 0, namely, the unique equilibrium point ðG; IÞ losses
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its stability and the system has a periodic solution, where s
and  satisfy (4.3).
C. Codimension-two bifurcation with parameters s
and 
In Secs. IVA and IVB, we have shown the existence of
Hopf bifurcation when the delay center s increases or, for
large s, when the delay interval radius  decreases from
large values. We now let both parameters s and  vary
simultaneously and investigate the codimension-two
bifurcation.
From (4.11), we see that s is a decreasing function of x,
while (4.12) implies that x is a decreasing function of .
Therefore, by (4.13), the Hopf bifurcation value of s
increases when the Hopf bifurcation value  increases, which
ensures the existence of a monotonic curve L formed by
Hopf bifurcation points in the (s; )-plane.
We take the data of subject no. 13 as an example for
simulation. Our intensive simulations confirm the existence
of the smooth curve L dividing the (s; )-plane into two
regions Ds, in which the equilibrium point is stable, and Du,
in which a limit cycle exists. As expected by the analytical
result given by (4.13), no degeneracy is found in our numeri-
cal investigations. Furthermore, (4.13) shows that L is a
monotonic curve. For clarity, we plot the curve L only in the
window ½180; 280  ½10; 180 in the (s; )-plane in Fig. 1.
Remark 4.5. As aforementioned, under the clinical setup
of IVGTT, the glucose and insulin concentrations will return
to their basal levels, respectively. So, the steady state (at the
basal levels) of the models that model the IVGTT should be
stable with reasonable parameter values in physiological
range. Figure 1 above and Figs. 4 and 5 in Sec. V show that
Hopf bifurcation would only occur when the delay parameter
values are large and out of physiological range.
V. SIMULATIONS
We have performed extensive numerical simulations
using experimental data listed in Tables I and II in Ref. 26,
which originated from Refs. 18 and 24, and the example data
in Penn Millennium MINMOD,12 a commercial software
developed according to MM. We compared the parameter
values estimated by our model to those in Refs. 18, 24, and
26 and Penn Millennium MINMOD. The profiles of our
numerical simulations are shown in Figs. 2 and 3. The esti-
mated parameters are listed in Tables I and II, respectively.
Comparison of estimated parameter values Sg and Si are
shown in Table III. We noticed that the profiles obtained by
Model (1.3) fit the data better in the following aspects.
(a) From Figs. 2 and 3, we observe that after a rapid insu-
lin secretion, the insulin level may decline dramatically
and rebound slightly;
(b) From Table III, we see that the glucose effectiveness
index Sg is smaller than that estimated by Penn
Millennium MINMOD,12 which improves the known
issue that MM overestimates the glucose effective-
ness;15,16 and
(c) From Table III, we see that the values of Sg in all simu-
lations are in a realistic range, which may not be true
for the results presented in Refs. 24 and 26.
We estimate the model parameters in a hybrid fashion.
We initially determine the parameter values by the Least
Square Method (LSM) and then empirically fine-tuned the
values to fit the data. This allows us to search for better fit-
tings that match well with the initial rapid insulin secretion,
subsequent decline in insulin levels and the second peak
FIG. 1. Codimension-two bifurcation diagram for the subject no. 13 in Ref.
24 produced by Model (1.3). The bifurcation curve L divides the (s; )-plane
into a stable region Ds and an unstable region Du.
TABLE I. Parameter values estimated by Model (1.3) for subject nos. 6, 7,
8, and 13 in Ref. 26.
Subjects No. 6 No. 7 No. 8 No. 13
Sg 1.6150 1002 2.1810 1002 1.5998 1002 3.5000 1002
Si 5.4371 1005 2.0191 1004 3.5585 1005 2.3000 1005
b 1.7431 10þ00 2.5178 10þ00 1.4085 10þ00 2.6379 10þ00
r 1.6388 10þ02 2.1861 10þ01 1.4109 10þ01 3.5340 1001
a 4.2050 10þ02 9.9628 10þ01 1.0000 10þ02 2.0000 10þ02
di 9.9250 1002 2.0946 1001 6.0000 1002 1.0500 1001
s 8.2500 10þ00 1.2369 10þ01 1.4250 10þ01 1.8000 10þ01
 2.0000 10þ00 5.0000 10þ00 3.0000 10þ00 9.0000 10þ00
GM 2.2547 10þ02 2.9937 10þ02 2.2642 10þ02 1.8340 10þ02
Gm 5.5929 10þ01 2.1908 10þ01 1.0448 10þ01 1.0307 10þ01
IM 4.1321 10þ02 1.7945 10þ02 1.0314 10þ03 2.3100 10þ02
Im 6.1622 10þ00 2.0800 1001 7.3000 1003 3.2100 1002
TABLE II. Parameter values estimated by Model (1.3) for Subject 27 in
Ref. 26, MM Ex 1 and MM Ex 2 in Ref. 12.
Subjects No. 27 MM Ex 1 MM Ex 2
Sg 1.3630 1003 2.0600 1002 8.2897 1003
Si 6.2029 1005 2.4930 1004 7.5621 1004
b 3.5386 1001 1.8936 10þ00 1.5279 10þ00
r 1.7705 10þ01 1.0716 10þ03 5.7475 10þ00
a 9.7757 10þ01 7.0404 10þ02 1.0504 10þ02
di 9.9375 1002 1.6900 1001 1.9030 1001
s 1.3914 10þ01 1.4066 10þ01 1.0066 10þ01
 3.0000 10þ00 5.0000 1001 5.0000 10þ00
GM 3.4590 10þ02 3.1400 10þ02 3.5000 10þ02
Gm 3.7389 10þ00 1.2628 10þ01 5.1966 10þ00
IM 1.0360 10þ03 2.2900 10þ02 2.3869 10þ02
Im 2.8365 10011 1.6000 1004 7.8862 1004
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(if any) due to a new round of insulin secretion, in addition
to other data points. While the initial condition of the insulin
concentration I is set at I(0), the initial condition of the glu-
cose concentration G is given by (1.7) with fixed value d¼ 2
(min) in observation that the bolus of glucose is injected
within two minutes in IVGTT. Every parameter has its
physiological meaning, and thus, their values are positive.
On the other hand, when consider them in the context of
mathematics, any parameter value can be negative or zero,
which would result in the parameter values do not reflect
physiological characteristics. To avoid this, we set the con-
straints for the parameters in positive intervals.
FIG. 2. Simulation profiles obtained
by Model (1.3) for subject nos. 6, 7, 8,
and 13. Estimated parameter values are
in Table I. The dots and diamonds are
glucose data and insulin data, respec-
tively. The curves are model profiles.
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FIG. 3. Simulation profiles obtained
by Model (1.3) for subject no. 27, Penn
Millennium Ex 1 and Ex 2. Estimated
parameter values are in Table II. The
dots and diamonds are glucose data
and insulin data, respectively. The
curves are model profiles.
TABLE III. Comparison between the values of parameter Sg, Si, and delay parameters estimated by Model (1.3), Penn Millennium MM
12 and Model(1) in
Ref. 26.
Subjects Model Sg Si Delay
MM Ex 1 Model(1.3) 2.0600 1002 2.4930 1004 [1.4566 10þ01, 1.3566 10þ01]
Minimal Model12 2.4594 1002 2.8526 10þ00 …
MM Ex 2 Model(1.3) 8.2897 1003 7.5621 1004 [1.5066 10þ01, 5.0661 10þ00]
Minimal Model12 9.5426 1003 7.4555 10þ00 …
#6 Model(1.3) 1.6150 1002 5.4371 1005 [1.0250 10þ01, 6.2500 10þ00]
Li et al.26 6.5973 1003 6.7604 1005 8.0662 10þ00
#7 Model(1.3) 2.1810 1002 2.0191 1004 [1.7369 10þ01, 7.3688 10þ00]
Li et al.26 3.6921 1004 1.0081 1006 1.0169 10þ01
#8 Model(1.3) 1.5998 1002 3.5585 1005 [1.7250 10þ01, 1.1250 10þ01]
Li et al.26 1.1990 1002 3.0209 1005 5.3818 10þ00
#13 Model(1.3) 3.5000 1002 2.3000 1005 [2.7000 10þ01, 9.0000 10þ00]
Li et al.26 8.7969 1003 1.1761 1004 1.8000 10þ01
#27 Model(1.3) 1.3630 1003 6.2029 1005 [1.6914 10þ01, 1.0914 10þ01]
Li et al.26 2.9076 1005 6.3829 1005 3.0000 10þ00
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We have analytically shown the existence of Hopf bifur-
cation when the delay parameter s increases from small, and
 decreases from large, respectively. Taking the subject no.
13 as an example, we demonstrated the bifurcation in Fig. 4
when s increases, and in Fig. 5 when  decreases, respec-
tively, while all other parameter values are fixed. Figure 4
indicates that a Hopf bifurcation takes place at s0 	 211,
while Fig. 5 indicates that a Hopf bifurcation takes place
when 0 	 110. Apparently, in such cases, the delay parame-
ter values are out of physiological meaningful range. That is
to say, with physiological meaningful parameter values,
Model (1.3) predicts that the equilibrium is stable.
VI. DISCUSSION
It is known that MM overestimates the glucose effec-
tiveness index Sg.
15,16 The estimated values of Sg by our
model (1.3) are more reasonable than those obtained by MM
and the models in Refs. 24 and 26.This is achieved through
better model fitting to the data set by adjusting the two
parameters s and , which together describe the insulin secre-
tion time delay interval.
Often, larger time delay in a delay differential equation
system destabilizes the system through a Hopf bifurcation.
The delayed effect of insulin secretion in response to the rap-
idly elevated glucose level is normally ranged in a few
minutes to less than half of an hour. Our numerical simula-
tions show that the Model (1.3) remains asymptotically sta-
ble for the delay value in physiological range. The Hopf
bifurcation does not occur if the delay center is smaller than
two hours. This indicates that in a typical clinical setting, the
destabilization will not be a concern and the dynamics of
glucose and insulin will approach their basal levels within
three hours.
In this paper, we propose a novel approach to model the
delayed effect in the past sub-interval centered at t  s with
radius . Such approach is also applicable to other disci-
plines. Our analytical analysis and numerical study show
that the delay center plays the major role and the delay radius
takes the secondary role. We summarize our main mathemat-
ical findings as follows:
(A) when the delay center is fixed, the smaller the radius of
the distribution interval of the delay, the more likely the
system could be destabilized;
FIG. 4. The emerged limit cycles of the parameter s 2 ½180; 280 while ¼ 5
for the subject #13 in Ref. 24 produced by Model (1.3) with parameters Si ¼
0:00015; b ¼ 0:41552; di ¼ 0:08; r ¼ 39:5193; Sg ¼ 0:002; a ¼ 200 and
n ¼ 3:1.
FIG. 5. The emerged limit cycles of the parameter  2 ½10; 190 with
s¼ 275 for the subject no. 13 in Ref. 24 produced by Model (1.3) with
parameters Si ¼ 0:00015; b ¼ 0:41552; di ¼ 0:08;r ¼ 39:5193; Sg ¼ 0:002;
a ¼ 200 and n ¼ 3:1.
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(B) for a certain and finite time horizon, when the radius of
the delay interval is fixed, the farther away of the delay
center from the current time, the more likely the system
could be destabilized.
We point out that the delay over the past sub-interval
can be realized by selecting the kernel
xðhÞ ¼
1
2
; h 2 s ; sþ ½ 
0; otherwise;
8<
:
in the general delay form over the full past intervalðsþ
0
xðhÞGðt  hÞdh:
Minimal Model (MM) received its name since it has only
three parameters, the minimal number of parameters in all
well known IVGTT models. Model (1.3) has six parameters
(notice that the parameter b is solvable by assuming its equi-
librium point at the basal levels of glucose and insulin con-
centrations, respectively). If one model, say model 1,
contains all the parameters of another model, say model 2,
and the model 1 becomes model 2 when parameters not used
in model 2 are set to be zero, then one can expect that model
1 shall fit data at least as good as model 2. Otherwise, more
parameters in a model may not ensure better data fitting. In
Everett et al.28 and in Rutter et al.,29 the authors reported
that simpler ad hoc models actually fit data slightly better
than their more complex models. However, Everett et al.28
found that their more complex and realistic models do pro-
vide better predictions.
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APPENDIX A: PROOF OF THEOREM 4.2
Proof. We need only to show that the conjugate imagi-
nary roots of (4.1) cross the imaginary axis from right to left,
that is,
dReðkÞ
ds

k¼ix^
> 0:
From (4.1), we have
dk
ds
2kþ a  h
2k2
e sþð Þk  e sð Þkð Þ
 
þ h
2k
e sþð Þk sþ ð Þ  e sð Þk s ð Þ
	 

¼ h
2
e sþð Þk  e sð Þkð Þ:
Hence,
dk
ds
 1
¼
2kþ a  h
2k2
ðe sþð Þk  e sð ÞkÞ þ h
2k
e sþð Þk sþ ð Þ  e sð Þk s ð Þ
	 

h
2
e sþð Þk  e sð Þkð Þ
:
At k ¼ ix^, we have
sgn
dRe kð Þ
ds
 
k¼ix^
( )
¼ sgn dRe kð Þ
ds
 1
k¼ix^
( )
¼ sgn Re dk
ds
 1
k¼ix^
 !( )
¼ sgn
2x^ððsin sþ ð ÞÞx^  sinð ðs Þx^Þ


þ a cosð sþ ð Þx^Þ  cosððs  x^ÞÞ
1
2
cosð sþ ð Þx^Þ  cosð s ð Þx^Þ 2 þ ðsinððsþ Þx^Þ  sinððs Þx^Þ2h i
8><
>:
þ
h
2x^2
ð2 2 cos sþ ð Þx^ð Þ cos ðs Þx^ð Þ  2 sin sþ ð Þx^ð Þsin s ð Þx^ð Þ  h
x^
sin 2x^ð Þ
1
2
cosð sþ ð Þx^Þ  cosð s ð Þx^Þ 2 þ ðsin sþ ð Þx^Þ  sin ððs Þx^ÞÞ2h i
9>=
>;
¼ sgn x^ cos sx^ð Þ sin x^ð Þ  2 sin sx^ð Þ sin x^ð Þa þ h
2x^2
2 2 cos 2x^ð Þð Þ  h
x^
sin 2x^ð Þ
 
¼ sgn 4x^ x^
2  cð Þx^
h
þ 2a ax^
2
h
þ h
x^2
1 cos 2x^ð Þð Þ  h
x^
sin 2x^ð Þ
( )
¼ sgn 4x^
4
h
þ 2x^
2
h
a2  2cð Þ þ 2h
x^
sin x^ð Þ sin x^ð Þ
x^
 cos x^ð Þ
  
¼ 1 for 0 < x^ < p

;
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which is ensured by a2  2c > 0 and sin x  x cos x > 0 for 0 < x < p. Therefore, (1.3) undergoes a bifurcation when s ¼
1
x^ cot
1 x^2c
ax^
	 

for 0 < x^ < p. 
APPENDIX B: PROOF OF THEOREM 4.4
Proof. Again, we need only to show that
dRe kð Þ
d

k¼ix^
< 0:
From (4.1), we can get that
2k3 þ 2ak2 þ 2ckþ h e sþð Þk  e sð Þkð Þ ¼ 0; for k 6¼ 0:
Hence
dk
d
 1
¼ 6k
2 þ 4akþ he sþð Þk sþ ð Þ þ he sð Þk sþ ð Þ þ 2c
2k3  2ak2  hk e sþð Þk þ e sð Þkð Þ  2kc ;
and thus, at k ¼ ix,
dk
d
 1
k¼ix^
¼ P
Q
;
where
P ¼ 6x2 þ 2c þ h cosð sþ ð ÞxÞ sþ ð Þ þ cos ð s ð ÞxÞ sþ ð Þ 
þ i 4ax þ h sin ð sþ ð ÞxÞ sþ ð Þ þ sin ð s ð ÞxÞ sþ ð Þ  ;
Q ¼ 2ax2 þ hx sin ð sþ ð Þx þ sin ð s ð ÞxÞÞþi 2x3  2cx  hx cosð sþ ð Þx þ cos ððs ÞxÞÞ :
Therefore
sgn Re
dk
d
 1
k¼ix
( )( )
¼ sgnf4ax4 4acx2þ 2ashx2 2ahx2ð Þ cos ð sþ ð ÞxÞ
þ 2ashx2 2ahx2ð Þcos ð s ð ÞxÞ þ 4hx3 2hsx3þ 2chsxð Þ sin ð sþ ð ÞxÞ
þ 4hx3þ 2hsx3 2chsxð Þ sin ð s ð ÞxÞ þ 2sxh sin 2xð Þ
¼ sgnf4acx4 4acx2þ 2ashx2 2ahx2ð Þcos sxð Þcos xð Þ
þ 2ashx2 2ahx2ð Þ sin sxð Þ sin xð Þ þ 2ashx2 2ahx2ð Þ cos sxð Þcos xð Þ
 2ashx2 2ahx2ð Þ sin sxð Þ sin xð Þ  4hx3 2hsx3þ 2cxhsð Þ sin sxð Þcos xð Þ
þ 4hx3 2hsx3þ 2cxhsð Þcos sxð Þ sin xð Þ  4hx3 2hsx3þ 2cxhsð Þ
 sin sxð Þcos xð Þ  4hx3 2hsx3þ 2cxhsð Þ cos sxð Þ sin xð Þ þ 2sxh sin 2xð Þg
¼ sgnf4acx4 4acx2þ 4ahx2ð Þ cos sxð Þcos xð Þ þ 4ahx2ð Þ sin sxð Þ sin xð Þ
þ8hx3 sin sxð Þcos xð Þ þ 4hx3þ 4chxð Þ cos sxð Þ sin xð Þ þ 2sxh sin 2xð Þg:
From (4.2), we can get
sin sxð Þ sin xð Þ ¼ ax
2
h
and cos sxð Þ sin xð Þ ¼ x
2  cð Þx2
h
;
and
sin sxð Þ ¼ ax
2
h sin xð Þ and cos sx
ð Þ ¼ x
2  cð Þx
h sin xð Þ :
So, we finally have
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sgn
dRe kð Þ
d
 1
k¼ix
( )
¼ sgn Re dk
d
 1
jk¼ix
( )( )
¼ sgn 4acx4  4acx2  4a2sx4 þ 4a2x5 þ 4a2x3cð Þ

 cos x
ð Þ
sin xð Þ  4sx
4 x2  cð Þ2 þ 4sxh2 sin xð Þ cos xð Þg ¼ 1; for p
2
< x < p:
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